Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 21   

Articles published

ONTY 2.87 -0.14 (-4.65%)
price chart
Great Day For Cancer-Related Stocks: Oncothyreon Inc (USA) (ONTY ...
Oncothyreon Inc (USA) (NASDAQ:ONTY), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Galena Biopharma Inc (NASDAQ:GALE), Medivation Inc (NASDAQ:MDVN) and Exelixis, Inc. (NASDAQ:EXEL) all traded higher in sympathy with PBYI.
Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma ...  Motley Fool
Unusual 11 Mid-Day Movers 07/23: (PBYI) (DRL) (NQ) Higher; (UIS) (XLNX ...  StreetInsider.com (subscription)
Related articles »  
News Buzz - Alpha Natural Resources, Inc. (ANR), Oncothyreon Inc (USA ...
Oncothyreon Inc (USA) (NASDAQ:ONTY), a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer.
Related articles »  
Biotech Stocks In Novel Concerns- Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA ...
The stockholders of Oncothyreon Inc (USA) (NASDAQ:ONTY) [Trend Analysis] permitted an alteration to the firm's certificate of incorporation to surge the number of the firm's approved shares from 100,000,000 to 200,000,000.
Related articles »  
Biotech Unexpectedly Broke Concerns Barrier- DARA Biosciences Inc (NASDAQ ...
A developmental biotech firm, Oncothyreon Inc (USA) (NASDAQ:ONTY) [Trend Analysis] climbed more than over 17% in last trading session following a positive trial result from Puma Biotechnology's HER2-positive breast cancer therapy neratinib.
Related articles »  
Investor's Watch List � Turquoise Hill Resources (NYSE:TRQ), Oncothyreon ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) announced the presentation of data from a Phase 1 trial of ONT-10, an antigen-specific immunotherapy targeting MUC1, at the American Association of Clinical Oncology (ASCO) 2014 Annual Meeting in Chicago.
Related articles »  
Stocks Plunging �MasTec, Inc. (NYSE:MTZ), Advanced Semiconductor ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer.
Stocks to Watch - Oncothyreon, NASDAQ:ONTY, Ariad Pharmaceuticals ...
Talisman Energy Inc. (USA)(NYSE:TLM)increase+13.40% and closed at $11.17 on a traded volume of 37,460,191 shares, in comparison to 3.79 million shares of average trading volume.
Active Watch List: Altera Corp. (NASDAQ:ALTR), Qihoo 360 Technology (NYSE ...
Ltd. (NYSE:QIHU) return on investment (ROI) is 5.50% while return on equity (ROE) is 21.00%. Return on Investment for Oncothyreon Inc (NASDAQ:ONTY) its shares closed at $3.01. Oncothyreon Inc (NASDAQ:ONTY) monthly performance stands at -8.23% ...
Related articles »  
Xilinx, Inc., Juniper Networks, iRobot Corporation Stumble Following Results ...
Oncothyreon Inc (NASDAQ:ONTY), Intuitive Surgical, Inc. (NASDAQ:ISRG) and Biogen Idec Inc (NASDAQ:BIIB) made major gains on the market midday.
Related articles »  
Notable Movers�Oncothyreon (NASDAQ:ONTY), Apollo Investment (NASDAQ ...
Las Vegas, NV - July 25, 2014 - (Tech Sonian) �OncothyreonInc (USA) (ONTY) announced the presentation of data from a Phase 1 trial of ONT-10, an antigen-specific immunotherapy targeting MUC1, at the American Association of Clinical Oncology ...
Related articles »